Cargando…
Optical control of insulin release using a photoswitchable sulfonylurea
Sulfonylureas are widely prescribed for the treatment of type 2 diabetes mellitus (T2DM). Through their actions on ATP-sensitive potassium (K(ATP)) channels, sulfonylureas boost insulin release from the pancreatic beta cell mass to restore glucose homeostasis. A limitation of these compounds is the...
Autores principales: | Broichhagen, Johannes, Schönberger, Matthias, Cork, Simon C., Frank, James A., Marchetti, Piero, Bugliani, Marco, Shapiro, A. M. James, Trapp, Stefan, Rutter, Guy A., Hodson, David J., Trauner, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208094/ https://www.ncbi.nlm.nih.gov/pubmed/25311795 http://dx.doi.org/10.1038/ncomms6116 |
Ejemplares similares
-
Optical control of a receptor-linked guanylyl cyclase using a photoswitchable peptidic hormone
por: Podewin, Tom, et al.
Publicado: (2017) -
Optical Control of Insulin Secretion Using an Incretin Switch
por: Broichhagen, Johannes, et al.
Publicado: (2015) -
Photoswitchable fatty acids enable optical control of TRPV1
por: Frank, James Allen, et al.
Publicado: (2015) -
Optical manipulation of sphingolipid biosynthesis using photoswitchable ceramides
por: Kol, Matthijs, et al.
Publicado: (2019) -
Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose
por: Johnston, Natalie R., et al.
Publicado: (2016)